TownSquare Capital’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $484K | Sell |
4,259
-32,515
| -88% | -$3.7M | 0.05% | 349 |
|
|
2025
Q1 | $3.87M | Buy |
36,774
+2,235
| +6% | +$235K | 0.04% | 385 |
|
|
2024
Q4 | $3.7M | Buy |
34,539
+4,726
| +16% | +$506K | 0.04% | 390 |
|
|
2024
Q3 | $2.98M | Buy |
29,813
+3,140
| +12% | +$314K | 0.04% | 431 |
|
|
2024
Q2 | $2.25M | Buy |
+26,673
| New | +$2.25M | 0.03% | 478 |
|
|
2022
Q2 | – | Sell |
-6,891
| Closed | -$484K | – | 752 |
|
|
2022
Q1 | $484K | Buy |
6,891
+1,109
| +19% | +$77.9K | 0.01% | 501 |
|
|
2021
Q4 | $557K | Buy |
5,782
+3,193
| +123% | +$308K | 0.01% | 460 |
|
|
2021
Q3 | $225K | Buy |
+2,589
| New | +$225K | 0.01% | 643 |
|